NEWZEALAND CLINICAL TRAIL TO TEST POTENTIAL OF NEW DRUGS TO
Posted: Sat Jun 18, 2016 2:52 am
Seeva, it would be really helpful if you gave a tiny clue what these random articles are about along with the links.seeva wrote:Hi fiends please read
http://multiplesclerosisnewstoday.com/2 ... -hospital/
regards
seeva
This random article is apparently about two antipsychotic meds, clozapine & risperidone, already FDA approved, that they think they'll try on MS patients next. They "repurpose" drugs from other medical conditions (see below), which will probably raise the price for us as well...
At least it's aimed at Secondary Progressive MS.
According to Professor La Flamme, repurposing medicines is an approach often used in MS drug development. “The majority of agents used to treat the most common form of MS — relapsing remitting MS — were originally used for something else, like viral infections and leukaemia,” she said in a news release. “We’re looking at two medications, clozapine and risperidone, which were designed to treat a variety of health disorders such as schizophrenia, bipolar disorder and autism.”